June 20, 2012 · Leave a Comment
New Therapies Show Some Promise Against Pancreatic Cancer
Giving four weeks of a targeted drug before starting chemotherapy improved response rates in a small group of patients with advanced pancreatic cancer, University of Michigan researchers report…”I think this trial here is a step back in the right direction of finding out what exactly is going on. I will say that when I read […]
View full entry Comment on this
Tags: Chemotherapy, Dr. Daniel Von Hoff, gemcitabine, HealthDay, pancreatic cancer, Translational Genomics Research Institute, University of Michigan